Albumin-binding derivatives of therapeutic peptides

Details for Australian Patent Application No. 2004273573 (hide)

Owner Novo Nordisk A/S

Inventors Dorwald, Florencio Zaragoza; Hansen, Thomas Kruse; Bloch, Paw; Johansen, Nils Langeland; Madsen, Kjeld; Lau, Jesper

Agent Shelston IP

Pub. Number AU-B-2004273573

PCT Pub. Number WO2005/027978

Priority 60/526,847 04.12.03 US; PA 2003 01367 19.09.03 DK; 60/505,739 25.09.03 US; PA 2003 01789 04.12.03 DK

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 22 April 2010

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/027978 Priority application(s): WO2005/027978

22 April 2010 Application Accepted

  Published as AU-B-2004273573

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273574-Buccal formulations of galanthamine and uses thereof

2004273558-Method for introducing cosmetics into the skin